Possibility of generating lung tissue for transplant using a patient’s own cells
For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center (CUMC) researchers, has significant potential for modeling lung disease, screening drugs, studying human lung development, and, ultimately, generating lung tissue for transplantation. The study was published today in the journal Nature Biotechnology.
“Researchers have had relative success in turning human stem cells into heart cells, pancreatic beta cells, intestinal cells, liver cells, and nerve cells, raising all sorts of possibilities for regenerative medicine,” said study leader Hans-Willem Snoeck, MD, PhD, professor of medicine (in microbiology & immunology) and affiliated with the Columbia Center for Translational Immunology and the Columbia Stem Cell Initiative. “Now, we are finally able to make lung and airway cells. This is important because lung transplants have a particularly poor prognosis. Although any clinical application is still many years away, we can begin thinking about making autologous lung transplants—that is, transplants that use a patient’s own skin cells to generate functional lung tissue.”
The research builds on Dr. Snoeck’s 2011 discovery of a set of chemical factors that can turn human embryonic stem (ES) cells or human induced pluripotent stem (iPS) cells into anterior foregut endoderm—precursors of lung and airway cells. (Human iPS cells closely resemble human ES cells but are generated from skin cells, by coaxing them into taking a developmental step backwards. Human iPS cells can then be stimulated to differentiate into specialized cells—offering researchers an alternative to human ES cells.)
In the current study, Dr. Snoeck and his colleagues found new factors that can complete the transformation of human ES or iPS cells into functionawebl lung epithelial cells (cells that cover the lung surface). The resultant cells were found to express markers of at least six types of lung and airway epithelial cells, particularly markers of type 2 alveolar epithelial cells. Type 2 cells are important because they produce surfactant, a substance critical to maintain the lung alveoli, where gas exchange takes place; they also participate in repair of the lung after injury and damage.
The findings have implications for the study of a number of lung diseases, including idiopathic pulmonary fibrosis (IPF), in which type 2 alveolar epithelial cells are thought to play a central role. “No one knows what causes the disease, and there’s no way to treat it,” says Dr. Snoeck. “Using this technology, researchers will finally be able to create laboratory models of IPF, study the disease at the molecular level, and screen drugs for possible treatments or cures.”
“In the longer term, we hope to use this technology to make an autologous lung graft,” Dr. Snoeck said. “This would entail taking a lung from a donor; removing all the lung cells, leaving only the lung scaffold; and seeding the scaffold with new lung cells derived from the patient. In this way, rejection problems could be avoided.” Dr. Snoeck is investigating this approach in collaboration with researchers in the Columbia University Department of Biomedical Engineering.
The Latest on: Human stem cells
- Rat cells grew in mice brains, and helped sniff out cookieson April 25, 2024 at 8:01 am
When implanted into mouse embryos, stem cells from rats grew into forebrains and structures that handle smells.
- Scientists regenerate neural pathways in mice with cells from ratson April 25, 2024 at 8:00 am
Two independent research teams have successfully regenerated mouse brain circuits in mice using neurons grown from rat stem cells. Both studies, published April 25 in the journal Cell, offer valuable ...
- Hybrid Brains With Both Rat And Mouse Cells Created In Landmark Double Firston April 25, 2024 at 7:00 am
In a world first, two teams of scientists have independently created hybrid brain tissue with cells from two species: mice and rats. These two fuzzy rodents might look similar on the outside, but ...
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseon April 25, 2024 at 6:00 am
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- New device improves stem cell generation and chance for accessible Alzheimer's cell therapyon April 24, 2024 at 12:11 pm
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance that they say helps close the gap for accessible personalized cell-based ...
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 10:50 am
Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics ...
- Portuguese scientists create human stem cells to treat Machado-Joseph disease. What to knowon April 23, 2024 at 7:38 am
Portuguese scientists managed to create human stem cells from skin cells that have the potential for long-term treatment of Machado-Joseph disease.
- Human Embryonic Stem Cells Market Latest Trends, Size, Key Players, Revenue, Growth, and Forecast 2024 to 2032on April 18, 2024 at 10:00 pm
Report Ocean recently added a research report on “Human Embryonic Stem Cells Market”. The report includes an extensive analysis of the market’s characteristics, COVID-19 impact, size and growth, ...
- Immunotherapy Regenerative Medicine Clinic on Using Stem Cells to Activate the Body's Natural Healing Poweron April 18, 2024 at 10:02 am
Stem cell therapy, a cornerstone of regenerative medicine, has shown immense potential in treating autoimmune diseases, aging conditions, and ...
- Scientists grow human mini-lungs as animal alternative for nanomaterial safety testingon April 18, 2024 at 8:35 am
Human mini-lungs grown by University of Manchester scientists can mimic the response of animals when exposed to certain nanomaterials. The study is published in Nano Today.
via Bing News
The Latest on: Autologous lung graft
- Nivolumab by Bristol-Myers Squibb for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approvalon April 17, 2024 at 7:40 pm
Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL).
- Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalystson April 16, 2024 at 3:25 pm
Lyell Immunopharma's stock price rose over 20% YTD. It focuses on T-cell therapies for solid tumors and has 2 clinical-stage assets. Find out why LYEL stock is a Buy.
- Paragonix heart transplant trial cuts graft dysfunction by halfon April 16, 2024 at 6:09 am
The GUARDIAN-Heart trial consisted of 1,261 US adult patients and saw 32% drop in the use of post-transplant mechanical circulatory support.
- Lung transplant patients to trial ‘early-warning’ skin patcheson April 15, 2024 at 11:00 pm
Lung transplant patients are to be given “skin patches” from their donor in the hope it could cut organ rejection rates by half. The trial by Oxford University and NHS Blood and Transplant will ...
via Bing News